Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis (SENOMIC)
Survival and Axillary Relapse in Breast Cancer Patients With Sentinel Node Micrometastases Who Have Not Undergone Completion Axillary Clearance - a National Cohort Study
Sponsor: Centrallasarettet Västerås
Listed as NCT02049632, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Centrallasarettet Västerås, it has been updated 12 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2022 — Apr 2023 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Mar 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Mar 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centrallasarettet Västerås
- Karolinska Institutet
- Uppsala University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Gothenburg, Sweden , Helsingborg, Sweden , Kalmar, Sweden , Karlskrona, Sweden , Kristianstad, Sweden , Lidköping, Sweden , Linköping, Sweden , Lund, Sweden , Skövde, Sweden , Stockholm, Sweden and 9 more locations